SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 50.40
+1.39 (2.84%)
At close: Aug 11, 2026
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 3.87 billion as of August 11, 2026. Its market cap has increased by 27.50% in one year.
Market Cap
3.87B
Enterprise Value
3.30B
Revenue
860.07M
Ranking
n/a
PE Ratio
33.83
Stock Price
50.40
ChartMarket Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has decreased from 4.48B to 3.87B, a decrease of -13.54%. That is a compound annual growth rate of -3.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 3.87B | -5.82% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
| May 17, 2022 | 4.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.95B |
| Beijing Strong Biotechnologies,Inc. | 6.87B |
| Shanghai Runda Medical Technology | 6.36B |
| Maccura Biotechnology Co.Ltd | 5.65B |
| Cowealth Medical China | 4.93B |
| Thalys Medical Technology Group | 3.85B |
| Shanghai Labway Clinical Laboratory | 3.77B |
| Guangdong Hybribio Biotech | 3.67B |